Login / Signup

Characterization of the Intraclonal Complexity of Chronic Lymphocytic Leukemia B Cells: Potential Influences of B-Cell Receptor Crosstalk with Other Stimuli.

Andrea N MazzarelloMark FitchMartina CardilloAnita NgSabreen BhuiyaEsha SharmaDavide BagnaraJonathan E KolitzJacqueline C BarrientosSteven L AllenKanti R RaiJoanna RhodesMarc K HellersteinNicholas Chiorazzi
Published in: Cancers (2023)
Chronic lymphocytic leukemia (CLL) clones contain subpopulations differing in time since the last cell division ("age"): recently born, proliferative (PF; CXCR4 Dim CD5 Bright ), intermediate (IF; CXCR4 Int CD5 Int ), and resting (RF; CXCR4 Bright CD5 Dim ) fractions. Herein, we used deuterium ( 2 H) incorporation into newly synthesized DNA in patients to refine the kinetics of CLL subpopulations by characterizing two additional CXCR4/CD5 fractions, i.e., double dim (DDF; CXCR4 Dim CD5 Dim ) and double bright (DBF; CXCR4 Bright CD5 Bright ); and intraclonal fractions differing in surface membrane (sm) IgM and IgD densities. Although DDF was enriched in recently divided cells and DBF in older cells, PF and RF remained the most enriched in youngest and oldest cells, respectively. Similarly, smIgM High and smIgD High cells were the youngest, and smIgM Low and smIgD Low were the oldest, when using smIG levels as discriminator. Surprisingly, the cells closest to the last stimulatory event bore high levels of smIG, and stimulating via TLR9 and smIG yielded a phenotype more consistent with the in vivo setting. Finally, older cells were less sensitive to in vivo inhibition by ibrutinib. Collectively, these data define additional intraclonal subpopulations with divergent ages and phenotypes and suggest that BCR engagement alone is not responsible for the smIG levels found in vivo, and the differential sensitivity of distinct fractions to ibrutinib might account, in part, for therapeutic relapse.
Keyphrases